{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:12:59Z","timestamp":1793844779349,"version":"4.6.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.humimm.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T05:36:44Z","timestamp":1612589804000},"page":"362-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-3960","authenticated-orcid":false,"given":"Ai-ris Y.","family":"Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2021.01.004_b0005","series-title":"Immune mechanisms at the maternal-fetal interface: perspectives and challenges","first-page":"328","author":"PrabhuDas","year":"2015"},{"key":"10.1016\/j.humimm.2021.01.004_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0015","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.02332","article-title":"Multi-lineage potential of fetal cells in maternal tissue: A legacy in reverse","author":"Khosrotehrani","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.humimm.2021.01.004_b0020","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obs. Gynecol"},{"key":"10.1016\/j.humimm.2021.01.004_b0025","doi-asserted-by":"crossref","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","article-title":"Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus","volume":"2","author":"Lo","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0030","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0035","article-title":"202: Gestational Hypertension and Preeclampsia","author":"ACOG Practice Bulletin No","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0040","doi-asserted-by":"crossref","DOI":"10.1542\/neo.20-10-e561","article-title":"Maternal mortality in the united states: Updates on trends, causes, and solutions","author":"Collier","year":"2019","journal-title":"Neoreviews"},{"key":"10.1016\/j.humimm.2021.01.004_b0045","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, Challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.humimm.2021.01.004_b0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J. Matern. Neonatal Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aji.12000","article-title":"Complement in Pregnancy: A Delicate Balance","volume":"69","author":"Denny","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0065","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2009.06.124","article-title":"Complement production by trophoblast cells at the feto-maternal interface","author":"Bulla","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0075","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.molimm.2007.12.025","article-title":"Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium","volume":"45","author":"Bulla","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement Activation and Regulation in Preeclamptic Placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0085","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.01.004_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?","volume":"10","author":"Pierik","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0095","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","author":"Burwick","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2005.06.017","article-title":"The complement system in the pathophysiology of pregnancy","volume":"43","author":"Girardi","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","author":"Regal","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal Complement Activation in Preeclampsia","author":"Burwick","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0115","article-title":"Improved diagnosis of preeclampsia with severe features and end organ injury using complement activation measurement in urine and plasma","author":"C.M., V.","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/aji.12439","article-title":"The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia","volume":"75","author":"Lynch","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.humimm.2021.01.004_b0135","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13033","article-title":"Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells","volume":"80","author":"Banadakoppa","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"issue":"167","key":"10.1016\/j.humimm.2021.01.004_b0140","first-page":"e1","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obs. Gynecol"},{"key":"10.1016\/j.humimm.2021.01.004_b0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2017-212224","article-title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and\/or antiphospholipid antibodies","volume":"77","author":"Kim","year":"2018","journal-title":"Ann. Rheum. Dis"},{"key":"10.1016\/j.humimm.2021.01.004_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/apm.12796","article-title":"Placental pathologic lesions with a significant recurrence risk \u2013 what not to miss!","author":"Chen","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.humimm.2021.01.004_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2019.02.007","article-title":"Complement receptor-associated CD163 + \/CD18 + \/CD11c + \/CD206 - \/CD209 - expression profile in chronic histiocytic intervillositis of the placenta","author":"Hussein","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.humimm.2021.01.004_b0165","article-title":"T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh Cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and Regulatory T Cells in Mediating and Restraining Inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2021.01.004_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2019.102613","article-title":"Lower activation of CD4+ memory T cells in preeclampsia compared to healthy pregnancies persists postpartum","volume":"136","author":"Kieffer","year":"2019","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2567.2004.01869.x","article-title":"Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset","volume":"112","author":"Somerset","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.01.004_b0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0195","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.celrep.2019.04.109","article-title":"Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface","volume":"27","author":"Salvany-Celades","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.humimm.2021.01.004_b0200","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1073\/pnas.1003909107","article-title":"Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance","volume":"107","author":"Kahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2021.01.004_b0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00109-004-0608-2","article-title":"Tolerance, suppression and the fetal allograft","volume":"83","author":"Aluvihare","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0210","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.humimm.2016.09.001","article-title":"FoxP3 gene promoter polymorphism affects susceptibility to preeclampsia","volume":"77","author":"Norouzian","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0215","doi-asserted-by":"crossref","unstructured":"T.D. Metz, L.M. Nelson, G.J. Stoddard, R.M. Silver, FOXP3 gene polymorphisms in preeclampsia, in: American Journal of Obstetrics and Gynecology vol. 206 165.e1-165.e6 (Mosby Inc., 2012).","DOI":"10.1016\/j.ajog.2011.09.005"},{"key":"10.1016\/j.humimm.2021.01.004_b0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2249.2011.04493.x","article-title":"Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (T reg) pool with distinct subsets of T regs","volume":"167","author":"Steinborn","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2007.03397.x","article-title":"Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia","volume":"149","author":"Sasaki","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10703-1","article-title":"Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia","volume":"10","author":"Hu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2021.01.004_b0235","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3389\/fimmu.2018.01934","article-title":"Clonally Expanded Decidual Effector Regulatory T Cells Increase in Late Gestation of Normal Pregnancy, but Not in Preeclampsia, in Humans","volume":"9","author":"Tsuda","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0240","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0897.2011.00987.x","article-title":"Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia","author":"Toldi","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0245","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00052.2016","article-title":"Identifying immune mechanisms mediating the hypertension during preeclampsia","volume":"311","author":"LaMarca","year":"2016","journal-title":"Am. J. Physiol. \u2013 Regulat. Integr. Comparat. Physiol."},{"key":"10.1016\/j.humimm.2021.01.004_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2012.01.006","article-title":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia","author":"Darmochwal-Kolarz","year":"2012","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10641955.2015.1032054","article-title":"IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia","volume":"34","author":"Harmon","year":"2015","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.humimm.2021.01.004_b0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/CS20171059","article-title":"Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia","volume":"132","author":"Scroggins","year":"2018","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.humimm.2021.01.004_b0265","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells","volume":"). 352","author":"Arbore","year":"2016","journal-title":"Science (80-."},{"key":"10.1016\/j.humimm.2021.01.004_b0270","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.immuni.2013.11.015","article-title":"New Twist on an Ancient Innate Immune Pathway","volume":"39","author":"Lajoie","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.01.004_b0275","unstructured":"Committee on Obstetric Practice Society for Maternal-Fetal Medicine. Low-Dose Aspirin Use During Pregnancy. Obstet. Gynecol. (2018)."},{"key":"10.1016\/j.humimm.2021.01.004_b0280","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0285","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?","volume":"10","author":"Pierik","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0295","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/uog.15789","article-title":"Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.01.004_b0300","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1080\/14767058.2018.1543656","article-title":"Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis","volume":"33","author":"Wang","year":"2020","journal-title":"J. Matern. Neonatal Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0305","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.humimm.2021.01.004_b0310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120147","article-title":"Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice","volume":"3","author":"Garrett","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/j.humimm.2021.01.004_b0315","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2021.01.004_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.humimm.2021.01.004_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00478","article-title":"Therapeutic potential of regulatory T cells in preeclampsia-opportunities and challenges","volume":"10","author":"Robertson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6853","article-title":"Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation","volume":"7","author":"McDonald-Hyman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2021.01.004_b0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-065X.2008.00634.x","article-title":"CD4+ T-regulatory cells: Toward therapy for human diseases","volume":"223","author":"Allan","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2021.01.004_b0340","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: A phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.humimm.2021.01.004_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00846","article-title":"Immune checkpoint molecules in reproductive immunology","volume":"10","author":"Miko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0350","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2021.01.004_b0355","doi-asserted-by":"crossref","unstructured":"K. Leavey et al. Unsupervised Placental Gene Expression Profiling Identifies Clinically Relevant Subclasses of Human Preeclampsia. Hypertens. (Dallas, Tex. 1979) 68, 137\u201347 (2016).","DOI":"10.1161\/HYPERTENSIONAHA.116.07293"},{"key":"10.1016\/j.humimm.2021.01.004_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2019.06.384","article-title":"Both \u2018canonical\u2019 and \u2018immunological\u2019 preeclampsia subtypes demonstrate changes in placental immune cell composition","volume":"83","author":"Leavey","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.humimm.2021.01.004_b0365","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.placenta.2012.02.010","article-title":"Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction","volume":"33","author":"Prins","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.humimm.2021.01.004_b0370","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.118.11644","article-title":"Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia","volume":"73","author":"Maric-Bilkan","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.01.004_b0375","article-title":"Decidual-placental immune landscape during syngeneic murine pregnancy","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0380","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3389\/fimmu.2019.03065","article-title":"Transcriptional and Functional Programming of Decidual Innate Lymphoid Cells","volume":"10","author":"Vazquez","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0385","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal-fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2021.01.004_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofw100","article-title":"Antibody responses after analytic treatment interruption in human immunodeficiency virus-1-infected individuals on early initiated antiretroviral therapy","volume":"3","author":"Stephenson","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.humimm.2021.01.004_b0395","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jim.2014.11.006","article-title":"Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development","volume":"416","author":"Stephenson","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.humimm.2021.01.004_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.05.010","article-title":"Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis","author":"Hecker","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2021.01.004_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0000065","article-title":"Detection and characterization of cellular immune responses using peptide-MHC microarrays","author":"Soen","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.humimm.2021.01.004_b0410","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1172\/JCI68991","article-title":"Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation","volume":"123","author":"Xiong","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2021.01.004_b0415","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: Active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.01.004_b0420","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1172\/JCI43998","article-title":"Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2","volume":"120","author":"Hiby","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2021.01.004_b0425","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.118.11644","article-title":"Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia","volume":"73","author":"Maric-Bilkan","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.01.004_b0430","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2015.1037282","article-title":"The therapeutic potential of regulatory T cells for the treatment of autoimmune disease","volume":"19","author":"Bluestone","year":"2015","journal-title":"Exp. Opinion Therapeutic Targets"},{"key":"10.1016\/j.humimm.2021.01.004_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103208","article-title":"Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus","volume":"142","author":"Zhao","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science (80-.)"},{"key":"10.1016\/j.humimm.2021.01.004_b0445","doi-asserted-by":"crossref","unstructured":"J.W. Paul, et al. Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor, in: American Journal of Obstetrics and Gynecology vol. 216 283.e1-283.e14 (Mosby Inc., 2017).","DOI":"10.1016\/j.ajog.2016.08.027"},{"key":"10.1016\/j.humimm.2021.01.004_b0450","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.01.004_b0455","first-page":"175","article-title":"Immunological studies of human placentae: Complement components in pre-eclamptic chorionic villi","volume":"56","author":"Sinha","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0460","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.humimm.2021.01.004_b0465","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/aji.12586","article-title":"Complement component C1q as potential diagnostic but not predictive marker of preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0470","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00428-015-1759-y","article-title":"Placental C4d deposition is a feature of defective placentation: Observations in cases of preeclampsia and miscarriage","volume":"466","author":"Kim","year":"2015","journal-title":"Virchows Arch."},{"key":"10.1016\/j.humimm.2021.01.004_b0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jri.2015.03.004","article-title":"Preeclampsia in autologous and oocyte donation pregnancy: Is there a different pathophysiology?","volume":"109","author":"Lashley","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0480","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1373\/clinchem.2007.074401","article-title":"Innate Immune Response by Ficolin Binding in Apoptotic Placenta Is Associated with the Clinical Syndrome of Preeclampsia","volume":"53","author":"Wang","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.humimm.2021.01.004_b0485","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jri.2012.10.002","article-title":"Immunological and biochemical markers in preeclampsia","volume":"96","author":"Kestlerov\u00e1","year":"2012","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0490","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13041","article-title":"Humoral immunity in late-onset Pre-eclampsia and linkage with angiogenic and inflammatory markers","volume":"80","author":"Sarween","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2249.2012.04590.x","article-title":"Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia","volume":"169","author":"Halmos","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0500","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2249.1990.tb05240.x","article-title":"Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae","volume":"80","author":"Tedesco","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0505","doi-asserted-by":"crossref","unstructured":"L. Hering et al. Trophoblasts reduce the vascular smooth muscle cell proatherogenic response, in: Hypertension vol. 51 554\u2013559 (Lippincott Williams & Wilkins, 2008).","DOI":"10.1161\/HYPERTENSIONAHA.107.102905"},{"key":"10.1016\/j.humimm.2021.01.004_b0510","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.112.191817","article-title":"Autoantibody-mediated complement c3a receptor activation contributes to the pathogenesis of preeclampsia","volume":"60","author":"Wang","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.01.004_b0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0520","doi-asserted-by":"crossref","first-page":"1950879","DOI":"10.1155\/2018\/1950879","article-title":"Lower FOXP3 mRNA Expression in First-Trimester Decidual Tissue from Uncomplicated Term Pregnancies with a Male Fetus","volume":"2018","author":"Kieffer","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2021.01.004_b0525","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2007.03397.x","article-title":"Proportion of peripheral blood and decidual CD4 + CD25 bright regulatory T cells in pre-eclampsia","volume":"149","author":"Sasaki","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0530","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jri.2007.08.002","article-title":"Inadequate tolerance induction may induce pre-eclampsia","volume":"76","author":"Saito","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0535","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.6.3491","article-title":"A deficiency of placental IL-10 in preeclampsia","author":"Hennessy","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00573","article-title":"New paradigm in the role of regulatory T cells during pregnancy","author":"Tsuda","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.01.004_b0545","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/10641950802601237","article-title":"Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood","volume":"28","author":"Prins","year":"2009","journal-title":"Hypertens. Pregnancy"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:53:38Z","timestamp":1759319618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0198885921000112"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.01.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}